. Strategy to generate the UAS-jp strain. Representation of the P{XP}jp d04563 insertion before and after FLP-mediated removal of the upstream UAS promoter. Forward (F) and reverse (R) priming sites are indicated by green arrows and the expected amplicon sizes are indicated next to each insertion. The gel shows the bands obtained in PCR amplification with genomic DNA of OregonR (negative control), and the two P{XP}jp d04563 versions.
. Metabolomic analysis of Mhc-Gal4 OE and KD fly thoraxes. (A, B) OPLS-DA models allow discrimianion between the control and OE genotypes (A) and also between the control and KD genotypes (B). (C) relative abundance of metabolites, estimated as integrated peak area in the NMR spectrogram, showing statistically significant differences compared to the control Figure S3 . Unaffected cardiac parameters. Cardiac parameters that do not show any statistically significant differences with the control flies: heart period (HP), diastolic interval (DI), sistolic interval (SI) and arrhythmia index (AI), in parameters units are seconds. Figure S4 . Analysis of neurodevelopmental vs neurodegenerative effects. To minimise developmental defects and highlight neurodegeneration, flies were cultured at 18ºC to tamper GMR-Gal4 expression during development, and then for a week at 25ºC to get higher levels of Gal4 in differentiated retinal neurons. Retinas of control and KD flies were analysed at both time points, 1 day after eclosion and after 1 week at 25ºC. (n=3, ≥60 ommatidia each) Figure S5 . Alteration of Jp levels with nub-Gal4. The area of wing blades from flies bearing the nub-Gal4 driver without any UAS construct (control), with UAS-jp (OE), with UAS-jp RNAi (KD) or with both (OE + KD) was estimated. Only the OE wing blades have a statistical reduction in size, which is recovered by co-expression of UAS-jp
